Naltrexone and Scopolamine Rapidly Reduce Symptoms of Major Depressive Disorder (MDD): A Double Blinded Randomized Controlled Pilot Study

Home > Journals > Biomedical & Life Sciences | Medicine & Healthcare >OJD

ISSN Print: 2169-9658
ISSN Online: 2169-9674

Website: https://www.scirp.org/journal/ojd
E-mail: ojd@scirp.org

Citations h5-index & Ranking*

Submission

"Naltrexone and Scopolamine Rapidly Reduce Symptoms of Major Depressive Disorder (MDD): A Double Blinded Randomized Controlled Pilot Study"
written by N. Taub,
published by Open Journal of Depression, Vol.8 No.1, 2019

has been cited by the following article(s):

Google Scholar
CrossRef

[1]	The antidepressant efficacy of the muscarinic antagonist scopolamine: Past findings and future directions.
	2020

● Open Special Issues

● Published Special Issues

● Special Issues Guideline

OJD Subscription

E-Mail Alert

OJD Most popular papers

Publication Ethics & OA Statement

OJD News

Frequently Asked Questions

Follow SCIRP

Journals A-Z

Journals by Subject

Manuscript Tracking System

Open Access

Books

For Authors

Translation & Proofreading

Submission System Login

Sitemap

Peer-Review Resources

Frequently Asked Questions

Advertising

News

Volume & Issue

[1]	Rapid Acting Antidepressants Advances in Pharmacology, 2020 DOI:10.1016/bs.apha.2020.04.002